At the time of writing, Wave Life Sciences Ltd [WVE] stock is trading at $14.83, up 4.44%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WVE shares have gain 8.17% over the last week, with a monthly amount glided 76.34%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Wave Life Sciences Ltd [NASDAQ: WVE] stock has seen the most recent analyst activity on October 16, 2024, when Raymond James upgraded its rating to a Strong Buy but kept the price target unchanged to $22 for it. On September 19, 2024, B. Riley Securities initiated with a Buy rating and assigned a price target of $11 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $10 on September 09, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $11 as its price target on May 15, 2024. Leerink Partners upgraded its rating to Outperform for this stock on December 19, 2023, and upped its price target to $12. In a note dated July 05, 2023, Raymond James initiated an Outperform rating and provided a target price of $7 on this stock.
For the past year, the stock price of Wave Life Sciences Ltd fluctuated between $3.50 and $15.92. Currently, Wall Street analysts expect the stock to reach $19.43 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $14.83 at the most recent close of the market. An investor can expect a potential return of 31.02% based on the average WVE price forecast.
Analyzing the WVE fundamentals
According to Wave Life Sciences Ltd [NASDAQ:WVE], the company’s sales were 110.50M for trailing twelve months, which represents an -10.92% plunge. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -0.67%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -6.58 and Total Capital is -2.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 6.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.40 points at the first support level, and at 13.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.05, and for the 2nd resistance point, it is at 15.28.
Ratios To Look Out For
It is important to note that Wave Life Sciences Ltd [NASDAQ:WVE] has a current ratio of 0.99. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.89. Considering the valuation of this stock, the price to sales ratio is 20.79.
Transactions by insiders
Recent insider trading involved Francis Chris, that happened on Oct 16 ’24 when 0.21 million shares were sold. President and CEO, BOLNO PAUL completed a deal on Oct 16 ’24 to sell 90474.0 shares. Meanwhile, Officer CHRISTOPHER FRANCIS bought 0.21 million shares on Oct 16 ’24.
